ReviewNature protocols2026
CellRank: consistent and data view agnostic fate mapping for single-cell genomics.
Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AnnQ: reference-based quantification of cellular abnormality at single-cell resolution.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell RNA sequencing quantifies biological samples at an unprecedented scale, allowing us to decipher biological differentiation dynamics such as normal development or disease progression. As conventional single-cell RNA sequencing experiments are destructive by nature, reconstructing cellular trajectories computationally is an essential aspect of analysis pipelines. To infer trajectories in a consistent and scalable manner, we have developed CellRank. In its first iteration, CellRank quantitatively recovered trajectories from RNA velocity estimates and transcriptomic similarity. Given these data views, CellRank constructed a cell-cell transition matrix, inducing a Markov chain to automatically infer terminal states and describe their lineage formation. However, CellRank did not enable incorporating complementary data views such as experimental time points, pseudotime or stemness potential. To facilitate these and future views, CellRank 2 generalizes CellRank's trajectory inference framework to multiview single-cell data, leading to a general and scalable framework for cellular fate mapping. Overall, the CellRank framework enables the consistent quantification of cellular fate, combining complementary views and analyzing lineage priming consistently. Here we provide detailed protocols on how to run exemplary CellRank analyses at scale and across different data views. Using CellRank requires basic apprehension and knowledge of single-cell omics data and the Python programming language.
Indexed as
Identifiers
41611959What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.